Long-term posaconazole treatment and follow-up of rhino-orbital-cerebral mucormycosis in a diabetic girl

Pediatric Diabetes

Volumn 10, Issue 4, 2009, Pages 289-293

  Tarani, Luigi ^a   Costantino, Francesco ^a   Notheis, Gundula ^b   Wintergerst, Uwe ^b   Venditti, Mario ^a   Di Biasi, Claudio ^a   Friederici, Donata ^c   Pasquino, Anna Maria ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c Essex Pharma GmbH   (Germany)

Author keywords

Children; Diabetes mellitus; Follow up; POS; Rhinocerebral mucormycosis

Indexed keywords

AMPHOTERICIN B; C REACTIVE PROTEIN; GRANULOCYTE COLONY STIMULATING FACTOR; INSULIN; POSACONAZOLE; TEICOPLANIN;

ANTIBIOTIC THERAPY; ARTICLE; BLINDNESS; BREATHING DISORDER; CASE REPORT; CHILD; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DEBRIDEMENT; DEHYDRATION; DIABETIC COMA; DISEASE COURSE; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG RESPONSE; DRUG SUBSTITUTION; DRUG TOLERABILITY; DRUG WITHDRAWAL; ERYTHROCYTE SEDIMENTATION RATE; EXOPHTHALMOS; EYE INFLAMMATION; FEMALE; FEVER; FLUID THERAPY; FOLLOW UP; HUMAN; HYPERBARIC OXYGEN; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; LONG TERM CARE; MAXILLARY SINUS; MUCORMYCOSIS; NOSE SECRETION; NUCLEAR MAGNETIC RESONANCE IMAGING; OPHTHALMOPLEGIA; ORBIT TUMOR; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RHINITIS; RHINOORBITAL CEREBRAL MUCORMYCOSIS; RHINOORBITALCEREBRAL MUCORMYCOSIS; RHIZOPUS; SINUSITIS; TREATMENT FAILURE;

ANTIBIOTICS, ANTIFUNGAL; CENTRAL NERVOUS SYSTEM DISEASES; CHILD; DIABETES MELLITUS, TYPE 1; DIABETIC KETOACIDOSIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MUCORMYCOSIS; NOSE DISEASES; ORBITAL DISEASES; TIME FACTORS; TREATMENT OUTCOME; TRIAZOLES;

EID: 66649121988     PISSN: 1399543X     EISSN: 13995448     Source Type: Journal    
DOI: 10.1111/j.1399-5448.2008.00465.x     Document Type: Article

References (27)

1. Winkelstein JA, Marino MC, Johnston RB, Boyle J, Curnutte J, Gallin JI. Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine (Baltimore) 2000: 79: 155-169.
2. Ullmann AJ, Lipton JH, Vesole DH et al. Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease. N Engl J Med 2007: 356: 335-347.
3. Cornely OA, Maertens J, Winston DJ et al. Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia. N Engl J Med 2007: 356: 348-359.
4. De Pauw BE, Donnelly JP. Prophylaxis and aspergillosis - has the principle been proven? N Engl J Med 2007: 356: 409-411.
5. Bhadada S, Bhansali A, Reddy KS, Bhat RV, Kandelwal N, Gupta AK. Rhino-orbital-cerebral mucormycosis in type 1 diabetes mellitus. Indian J Pediatr 2005: 72: 671-674.
6. Herbrecht R, Denning DW, Patherson TF et al. Voriconazole versus amphotericin B for primary ofinvasive aspergillosis. N Engl J Med 2002: 347: 408-415.
7. Sun QN, Fothergill AW, Mc Carthy DI, Rinaldi MG, Graybill JR. In vivo activity of posaconazole against Mucor spp. in an immunosuppressed-mouse model. Antimicrob Agents Chemother 2002: 46: 2310-2312.
8. Gupta AK, Kohli Y, Batra R. In vitro activities of posaconazole, ravuconazole, terbinafine, itraconazole and fluconazole against dermatophyte, yeast and non-dermatophyte species. Med Mycol 2005: 43: 179-185.
9. Hof H. A new, broad-spectrum azole antifungal: Posaconazole. Mechanisms of action and resistance, spectrum of activity. Mycoses 2006: 49 (Suppl. 1): 2-6.
10. Pitisuttithum P, Negroni R, Graybill JR et al. Activity of posaconazole in the treatment of central nervous system fungal infections. J Antimicrob Chemother 2005: 56: 745-755.
11. Paugam A. The latest data on posaconazole. Med Mal Infect 2007: 37: 71-76.
12. Greer ND. Posaconazole (Noxafil): A new triazole antifungal agent. Proc (Bayl Univ Med Cent) 2007: 20: 188-196.
13. Cantatore-Francis JL, Shin HT, Heilman E, Glick SA. Primary cutaneous zygomycosis in two immunocompromised children. Pediatr Dermatol 2007: 24: 257-262.
14. Zirak C, Brutus JP, De Mey A. Atypical cause of foream skin ulceration in a leukaemic child: Mucormycosis. A case report. Acta Chir Belg 2005: 105: 551-553.
15. De Deker K, Van Poucke S, Wojciechowski M et al. Successful use of posaconazole in a pediatric case of fungal necrotizing fasciitis. Pediatr Crit Care Med 2006: 7: 482-485.
16. Segal BH, Barnhart LA, Anderson VL, Walsh TJ, Malech HL, Holland SM. Posaconazole as salvage therapy in patients with chronic granulomatous disease and invasive filamentous fungal infection. Clin Infect Dis 2005: 40: 1684-1688.
17. Hayeds D Jr. Nosocomial pulmonary Rhizopus diagnosed by bronchoalveolar lavage with cytology in a child with acute lymphoblastic leukemia. Pediatr Hematol Oncol 2006: 23: 323-327.
18. Gelston CD, Durairaj VD, Simoes EA. Rhino-orbital mucormycosis causing cavernous sinus and internal carotid thrombosis treated with posaconazole. Arch Ophthalmol 2007: 125: 848-849.
19. Grant JM, St-Germain G, Mc Donald JC. Successful treatment of invasive Rhizopus infection in a child with thalassemia. Med Mycol 2006: 44: 771-775.
20. Simmons JH, Zeitler PS, Fenton Lz, Abzug MJ, Fiallo-Sharer RV, Kligensmith GJ. Rhinocerebral mucormycosis complicated by internal carotid artery thrombosis in a pediatric patient with type 1 diabetes mellitus: A case report and review of literature. Pediatr Diabetes 2005: 6: 234-238.
21. Sasmaz I, Leblebisatan G, Antmen B, Binokay F, Tumali N, Kilinc Y. Cardiac mucormycosis in a child with severe aplastic anemia: A case report. Pediatr Hematol Oncol 2006: 23: 433-437.
22. Notheis G, Tarani L, Costantino F et al. Posaconazole for treatment of refractory invasive fungal disease. Mycoses 2006: 49 (Suppl. 1): 37-41.
23. Singh J, Rimek D, Kappe R. In vitro susceptibility of 15 strains of zygomycetes to nine antifungal agents as determined by the NCCLS M38-A microdilution method. Mycoses 2005: 48: 246-250.
24. Hamilton J, Bartkowsi HB, Rock J. Management of CNC mucormycosis in the pediatric patient. Pediatr Neurosurg 2003: 38: 212-215.
25. Chadli-Chaieb M, Bchir A, Fathallah-Mili A et al. [Mucormycosis in the diabetic patient.]. Presse Med 2005: 34: 218-222.
26. Bhansali A, Bhadada S, Sharma A et al. Presentation and outcome of rhino-orbital cerebral mucormycosis in patients with diabetes. Postgrad Med J 2004: 80: 670-674.
27. Brugiere O, Dauriat G, Mal H, et al. Pulmonary mucormycosis (zygomycosis) in a lung transplant recipient: Recovery after posaconazole therapy. Transplantation 2005: 80: 1361-1362.